Amtech Ester IPO (9 Sep-11 Sep) Analysis
Updated: Sep 11
Amtech Esters Limited is a business to business manufacturer of Unsaturated Polyester Resins (UPR) with a product portfolio of 49 SKUs. The company was founded in 2002 by Avtar Singh Bawa and is currently managed by Ajit Singh Bawa, Managing Director, who has over 24 years of experience in the chemicals industry. The company holds an ISO 9001:2015 certification for its quality management systems.
The company operates a manufacturing facility at Bahadurgarh, Jhajjar, Haryana with an installed capacity of 2,960 metric tonnes per annum (MTPA). Amtech Esters also owns a wholly owned subsidiary, Croda Pigments Private Limited (CPPL), which manufactures specialty pigments and colorants.
CPPL operates a manufacturing facility at the same location with a capacity of 382.2 MTPA. A new manufacturing facility is being set up at Asoda, Haryana with a capacity of 4,800 MTPA, funded through internal accruals, and is targeted for completion by September 2026.
Amtech Esters serves customers across multiple end use industries including automotive, fashion and apparel, electrical switchgear, artistic and decorative, and general industrial applications. Unsaturated polyester resins are widely used in composites, coatings, and moulding applications, making them a foundational input material across a broad range of manufacturing sectors in India.
IPO BASICS
Parameter | Details |
Issue Type | Pure Fresh Issue (no Offer for Sale) |
Fresh Issue Size | Up to 23,84,000 equity shares |
Face Value | Rs. 10 per share |
Listing | BSE SME Platform |
Anchor Date | September 8, 2026 |
IPO Open Date | September 9, 2026 |
IPO Close Date | September 11, 2026 |
BRLM | Credora Partners Private Limited |
Registrar | Maashitla Securities Private Limited |
This is a pure Fresh Issue with no Offer for Sale component, meaning the entire proceeds accrue to the company. Pre-IPO shares outstanding total 64,45,168 equity shares. Post-IPO, the total share capital will stand at 88,29,168 equity shares. The issue price has not been finalised in the Red Herring Prospectus.
The company is being listed on the BSE SME Platform, reflecting its small and medium enterprise scale. The promoters are Avtar Singh Bawa and Ajit Singh Bawa, both of whom have been associated with the business since inception.
USE OF PROCEEDS
The net proceeds from the Fresh Issue are proposed to be utilised as follows:
Purpose | Amount (Rs. Lakhs) |
Investment in CPPL by way of debt (capex + working capital) | 881.42 |
Repayment of borrowings | 419.73 |
Inorganic growth and General Corporate Purposes | Balance (not exceeding 35% of Gross Proceeds) |
The largest allocation of Rs. 881.42 Lakhs is earmarked for investment in the wholly owned subsidiary CPPL, split between capital expenditure of Rs. 341.42 Lakhs and working capital support of Rs. 540.00 Lakhs. This reflects the company's strategy to grow its pigments and colorants business through CPPL.
A further Rs. 419.73 Lakhs will be used for repayment of existing borrowings, improving the company's leverage position. The balance is reserved for inorganic growth initiatives and general corporate purposes, capped at 35% of gross proceeds.
FINANCIAL PERFORMANCE
Amtech Esters has delivered consistent revenue growth over the past three fiscal years. Revenue grew from Rs. 2,460.37 Lakhs in FY2024 to Rs. 4,067.12 Lakhs in FY2026, a compound annual growth rate (CAGR) of approximately 28.55%. The consolidation of CPPL as a wholly owned subsidiary in FY2023-24 has contributed to this growth trajectory, enhancing both the revenue base and product diversity of the group.
Metric | FY2024 | FY2025 | FY2026 |
Revenue (Rs. Lakhs) | 2,460.37 | 3,688.69 | 4,067.12 |
EBITDA (Rs. Lakhs) | 164.72 | 650.20 | 748.95 |
EBITDA Margin | 6.69% | 17.63% | 18.41% |
PAT (Rs. Lakhs) | 283.71 | 372.22 | 422.28 |
PAT Margin | 11.53% | 10.09% | 10.38% |
Net Worth (Rs. Lakhs) | 1,163.67 | 1,535.89 | 1,958.17 |
Debt to Equity Ratio | 0.39x | 0.26x | 0.17x |
EBITDA expanded sharply from Rs. 164.72 Lakhs in FY2024 to Rs. 748.95 Lakhs in FY2026, with EBITDA margins improving from 6.69% to 18.41%. The low EBITDA in FY2024 reflects transitional costs and consolidation effects arising from the integration of CPPL.
PAT has grown at a CAGR of approximately 22.00% from FY2024 to FY2026, and PAT margins have stabilised in the 10% range across FY2025 and FY2026. The debt to equity ratio has declined consistently from 0.39x in FY2024 to 0.17x in FY2026, indicating a low leverage and financially conservative business model.
Return on equity and return on capital employed have remained strong across all three years, reflecting the capital efficient nature of the business. RoCE of 30.16% in FY2026 indicates that the company generates meaningful returns on the capital deployed in the business. EPS has grown from Rs. 4.40 in FY2024 to Rs. 6.55 in FY2026, and NAV per share has increased from Rs. 18.05 to Rs. 30.38 over the same period.
PEER COMPARISON
The company operates in the specialty chemicals sector with a focus on unsaturated polyester resins and pigments. As explicitly stated in the Red Herring Prospectus, there are no listed peers operating in this specific industry segment.
Additionally, the company has noted that no suitable unlisted peers are available that are comparable in terms of size and scale of operations. Accordingly, no peer comparison table can be presented, and the industry P/E benchmark is not applicable.
In the absence of direct peers, the company's performance must be evaluated on a standalone basis. With RoCE of 30.16% and RoE of 24.17% in FY2026, the company demonstrates strong capital efficiency relative to the broader specialty chemicals industry. Revenue CAGR of approximately 28.55% and EBITDA margin of 18.41% in FY2026 indicate a well managed and growing business within its niche.
KEY RISKS
Concentration in a Single Product Category
The company derives the majority of its revenues from unsaturated polyester resins, a specialised chemical product. Dependence on a single product category exposes the company to demand fluctuations in specific end use industries such as automotive and electrical. Any technological shift that reduces demand for UPR in these sectors could materially affect revenues.
Raw Material Price Volatility
Unsaturated polyester resins are derived from petrochemical feedstocks, the prices of which are inherently volatile and linked to global crude oil markets. Sustained increases in raw material costs may compress margins if the company is unable to pass through price increases to its customers in a timely manner. As a B2B supplier, pricing power may be limited in competitive or oversupplied market conditions.
SME Scale and Limited Market Presence
Amtech Esters is a small to medium enterprise with revenues of Rs. 4,067.12 Lakhs in FY2026. Its scale is significantly smaller than large speciality chemical companies listed on main board exchanges. Limited scale can constrain bargaining power with both suppliers and customers, restrict access to large volume contracts, and limit the ability to invest in research and development.
Execution Risk in New Capacity
The company is setting up a new facility at Asoda, Haryana with a capacity of 4,800 MTPA funded through internal accruals. Any delays in commissioning, unexpected cost overruns, or slower than anticipated demand ramp up at the new facility could affect the company's projected revenue growth and return on capital.
Integration and Operational Risk at CPPL
A significant portion of the IPO proceeds is earmarked for investment in CPPL, the wholly owned subsidiary. CPPL is a smaller operation at 382.2 MTPA and is still scaling its pigments and colorants business. Any operational or management challenges at CPPL could affect its ability to utilise the capital efficiently and contribute to consolidated profitability.
KEY POSITIVES
Established Niche in Specialty Chemicals
Amtech Esters has carved out a focused position in unsaturated polyester resins, a technically specialised product segment. With 49 SKUs and over two decades of operational experience, the company has built a deep product knowledge base and customer relationships that are difficult for new entrants to replicate. Its ISO 9001:2015 certification reinforces product quality credibility with industrial buyers.
Improving Margins and Financial Discipline
EBITDA margins expanded from 6.69% in FY2024 to 18.41% in FY2026, reflecting the operational benefits of consolidating CPPL and achieving better scale efficiencies. The debt to equity ratio has consistently declined from 0.39x to 0.17x over the same period, indicating sound financial management and a preference for organic funding of growth rather than leverage.
Strong Capital Returns
The company has maintained RoCE above 30% in FY2024 and FY2026, and reached 35.10% in FY2025, demonstrating that it generates strong returns on the capital employed in the business. RoE has been sustained above 24% across all three years, indicating consistent profitability relative to the equity base.
Pure Fresh Issue Structure
As a pure Fresh Issue with no Offer for Sale component, the entire proceeds from the IPO flow into the company for business purposes including subsidiary investment, debt repayment, and growth. This structure aligns the interests of the company and new investors, as promoters are not monetising their stakes through the IPO.
Capacity Expansion Underway
The new Asoda facility with a capacity of 4,800 MTPA, once commissioned, will more than double the company's existing UPR production capacity of 2,960 MTPA. This positions Amtech Esters to serve larger customers and capture incremental demand without being constrained by capacity limitations. Being funded through internal accruals, the expansion is not expected to add financial risk to the balance sheet.
Diversification Through CPPL
The wholly owned subsidiary CPPL adds a distinct revenue stream in specialty pigments and colorants, which serves different end use industries and customer segments compared to the parent company's UPR business. As CPPL scales with the support of IPO proceeds, it has the potential to reduce revenue concentration risk and contribute meaningfully to group profitability over the medium term.
Disclaimer
The content on this website is for informational and educational purposes only and should not be construed as investment advice, a recommendation, or a solicitation to buy or sell any security, mutual fund, or financial instrument. Equity Research India is not a SEBI-registered investment advisor or research analyst, and nothing on this site constitutes personalized financial advice.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not indicative of future returns. NAV, returns, rankings, and other data may change and may not reflect the most current information at the time of reading.
Readers should conduct their own due diligence and consult a SEBI-registered financial advisor before making any investment decisions. Equity Research India and its authors accept no liability for any loss or damage arising from the use of this content.
Comments